MPO and diabetes mellitus: In patient groups with diabetes, statistically significant differences in terms of MPO activity was not detected among the patients using and not using sitagliptin, insulin detemir, insulin glargine, insulin aspart, insulin lispro, insulin glulisine, metformin, gliclazide, repaglinide, nateglinide, pioglitazone.